Adrenocortical zonation, renewal, and remodeling

Frontiers in Endocrinology

Volumn 6, Issue MAR, 2015, Pages

  Pihlajoki, Marjut ^a   Dörner, Julia ^b,c   Cochran, Rebecca S ^c   Heikinheimo, Markku ^a,c   Wilson, David B ^c  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF APPLIED SCIENCES   (Germany)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Adrenal cortex; Hormone; Plasticity; Stem cell; Steroid; Steroidogenesis

Indexed keywords

ACTIVIN; ANGIOTENSIN II; BETA CATENIN; CORTICOTROPIN; CYCLIC AMP; CYTOCHROME B5; DELTA LIKE HOMOLOG 1 PROTEIN; FIBROBLAST GROWTH FACTOR; INHIBIN; LUTEINIZING HORMONE; NUCLEAR RECEPTOR DAX 1; PROLACTIN; PROTEIN; SOMATOMEDIN; SONIC HEDGEHOG PROTEIN; STEROID 17ALPHA MONOOXYGENASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR SF1; TRANSCRIPTION FACTOR TCF21; TRANSCRIPTION FACTOR WT1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ADRENAL CORTEX; ADRENAL CORTEX CELL; ADRENALECTOMY; ADRENOCORTICAL CELL PLASTICITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL RENEWAL; EMBRYO DEVELOPMENT; HOMEOSTASIS; HUMAN; NONHUMAN; ORGANOGENESIS; PLASTICITY; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; STEM CELL; TISSUE REGENERATION; WNT SIGNALING PATHWAY; ZONA FASCICULATA; ZONA GLOMERULOSA;

EID: 84926680332     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2015.00027     Document Type: Review

References (114)

1. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev (2011) 32(1):81-151. doi: 10.1210/er.2010-0013
2. Yates R, Katugampola H, Cavlan D, Cogger K, Meimaridou E, Hughes C, et al. Adrenocortical development, maintenance, and disease. Curr Top Dev Biol (2013) 106:239-312. doi:10.1016/B978-0-12-416021-7.00007-9
3. Mitani F. Functional zonation of the rat adrenal cortex: the development and maintenance. Proc Jpn Acad Ser B Phys Biol Sci (2014) 90(5):163-83. doi:10.2183/pjab.90.163
4. Walczak EM, Hammer GD. Regulation of the adrenocortical stem cell niche: implications for disease. Nat Rev Endocrinol (2015) 11(1):14-28. doi:10.1038/nrendo.2014.166
5. Zelander T. The ultrastructure of the adrenal cortex of the mouse. Z Zellforsch Mikrosk Anat (1957) 46(6):710-6. doi:10.1007/BF00339373
6. Nussdorfer GG. Cytophysiology of the adrenal cortex. Int Rev Cytol (1986) 98:1-405.
7. Simon DP, Hammer GD. Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma. Mol Cell Endocrinol (2012) 351(1):2-11. doi:10.1016/j.mce.2011.12.006
8. Beuschlein F, Galac S, Wilson DB. Animal models of adrenocortical tumorigenesis. Mol Cell Endocrinol (2012) 351(1):78-86. doi:10.1016/j.mce.2011.09.045
9. Morohashi K, Zubair M. The fetal and adult adrenal cortex. Mol Cell Endocrinol (2011) 336(1-2):193-7. doi:10.1016/j.mce.2010.11.026
10. Hirokawa N, Ishikawa H. Electron microscopic observations on postnatal development of the X zone in mouse adrenal cortex. Z Anat Entwicklungsgesch (1974) 144(1):85-100. doi:10.1007/BF00518635
11. Hershkovitz L, Beuschlein F, Klammer S, Krup M, Weinstein Y. Adrenal 20alpha-hydroxysteroid dehydrogenase in the mouse catabolizes progesterone and 11-deoxycorticosterone and is restricted to the X-zone. Endocrinology (2007) 148(3):976-88. doi:10.1210/en.2006-1100
12. Guasti L, Cavlan D, Cogger K, Banu Z, Shakur A, Latif S, et al. Dlk1 upregulates Gli1 expression in male rat adrenal capsule cells through the activation of beta1 integrin and ERK1-2. Endocrinology (2013) 154(12):4675-84. doi:10.1210/en.2013-1211
13. Pihlajoki M, Heikinheimo M, Wilson DB. Never underestimate the complexity of remodeling. Endocrinology (2013) 154(12):4446-9. doi:10.1210/en.2013-1982
14. Gorrigan RJ, Guasti L, King P, Clark AJ, Chan LF. Localisation of the melanocortin-2-receptor and its accessory proteins in the developing and adult adrenal gland. J Mol Endocrinol (2011) 46(3):227-32. doi:10.1530/JME-11-0011
15. Bielinska M, Kiiveri S, Parviainen H, Mannisto S, Heikinheimo M, Wilson DB. Gonadectomy-induced adrenocortical neoplasia in the domestic ferret (Mustela putorius furo) and laboratory mouse. Vet Pathol (2006) 43(2):97-117. doi:10.1354/vp.43-2-97
16. Quinn TA, Ratnayake U, Dickinson H, Nguyen TH, McIntosh M, Castillo-Melendez M, et al. Ontogeny of the adrenal gland in the spiny mouse, with particular reference to production of the steroids cortisol and dehydroepiandrosterone. Endocrinology (2013) 154(3):1190-201. doi:10.1210/en.2012-1953
17. Wagner S, Kiupel M, Peterson RA, Heikinheimo M, Wilson DB. Cytochrome b5 expression in gonadectomy-induced adrenocortical neoplasms of the domestic ferret (Mustela putorius furo). Vet Pathol (2008) 45(4):439-42. doi:10.1354/vp.45-4-439
18. Bland ML, Desclozeaux M, Ingraham HA. Tissue growth and remodeling of the embryonic and adult adrenal gland. Ann N Y Acad Sci (2003) 995:59-72. doi:10.1111/j.1749-6632.2003.tb03210.x
19. Naffin-Olivos JL, Auchus RJ. Human cytochrome b5 requires residues E48 and E49 to stimulate the 17,20-lyase activity of cytochrome P450c17. Biochemistry (2006) 45(3):755-62. doi:10.1021/bi051623y
20. Pattison JC, Abbott DH, Saltzman W, Conley AJ, Bird IM. Plasticity of the zona reticularis in the adult marmoset adrenal cortex: voyages of discovery in the New World. J Endocrinol (2009) 203(3):313-26. doi:10.1677/JOE-08-0554
21. Topor LS, Asai M, Dunn J, Majzoub JA. Cortisol stimulates secretion of dehydroepiandrosterone in human adrenocortical cells through inhibition of 3betaHSD2. J Clin Endocrinol Metab (2011) 96(1):E31-9. doi:10.1210/jc.2010-0692
22. Hirokawa N, Ishikawa H. Electron microscopic observations on the castration-induced X zone in the adrenal cortex of male mice. Cell Tissue Res (1975) 162(1):119-30. doi:10.1007/BF00223267
23. Beuschlein F, Looyenga BD, Bleasdale SE, Mutch C, Bavers DL, Parlow AF, et al. Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Mol Cell Biol (2003) 23(11):3951-64. doi:10.1128/MCB.23.11.3951-3964.2003
24. Laufer E, Kesper D, Vortkamp A, King P. Sonic hedgehog signaling during adrenal development. Mol Cell Endocrinol (2012) 351(1):19-27. doi:10.1016/j.mce.2011.10.002
25. Bandiera R, Vidal VP, Motamedi FJ, Clarkson M, Sahut-Barnola I, von Gise A, et al. WT1 maintains adrenal-gonadal primordium identity and marks a population of AGP-like progenitors within the adrenal gland. Dev Cell (2013) 27(1):5-18. doi:10.1016/j.devcel.2013.09.003
26. Val P, Martinez-Barbera JP, Swain A. Adrenal development is initiated by cited2 and Wt1 through modulation of Sf-1 dosage. Development (2007) 134(12):2349-58. doi:10.1242/dev.004390
27. Wood MA, Acharya A, Finco I, Swonger JM, Elston MJ, Tallquist MD, et al. Fetal adrenal capsular cells serve as progenitor cells for steroidogenic and stromal adrenocortical cell lineages in M. musculus. Development (2013) 140(22):4522-32. doi:10.1242/dev.092775
28. Schulte DM, Shapiro I, Reincke M, Beuschlein F. Expression and spatio-temporal distribution of differentiation and proliferation markers during mouse adrenal development. Gene Expr Patterns (2007) 7(1-2):72-81. doi:10.1016/j.modgep.2006.05.009
29. Paul A, Laufer E. Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. Mol Cell Endocrinol (2011) 336(1-2):133-40. doi:10.1016/j.mce.2011.01.015
30. King P, Paul A, Laufer E. Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages. Proc Natl Acad Sci U S A (2009) 106(50):21185-90. doi:10.1073/pnas.0909471106
31. Mitani F, Ogishima T, Miyamoto H, Ishimura Y. Localization of P450aldo and P45011 beta in normal and regenerating rat adrenal cortex. Endocr Res (1995) 21(1-2):413-23. doi:10.3109/07435809509030457
32. Mitani F, Mukai K, Miyamoto H, Suematsu M, Ishimura Y. Development of functional zonation in the rat adrenal cortex. Endocrinology (1999) 140(7):3342-53. doi:10.1210/en.140.7.3342
33. Monticone S, Auchus RJ, Rainey WE. Adrenal disorders in pregnancy. Nat Rev Endocrinol (2012) 8(11):668-78. doi:10.1038/nrendo.2012.155
34. Goto M, Piper HK, Marcos J, Wood PJ, Wright S, Postle AD, et al. In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. J Clin Invest (2006) 116(4):953-60. doi:10.1172/JCI25091
35. Morley SD, Viard I, Chung BC, Ikeda Y, Parker KL, Mullins JJ. Variegated expression of a mouse steroid 21-hydroxylase/beta-galactosidase transgene suggests centripetal migration of adrenocortical cells. Mol Endocrinol (1996) 10(5):585-98. doi:10.1210/me.10.5.585
36. Freedman BD, Kempna PB, Carlone DL, Shah MS, Guagliardo NA, Barrett PQ, et al. Adrenocortical zonation results from lineage conversion of differentiated zona glomerulosa cells. Dev Cell (2013) 26(6):666-73. doi:10.1016/j.devcel.2013.07.016
37. Sahut-Barnola I, de Joussineau C, Val P, Lambert-Langlais S, Damon C, Lefrancois-Martinez AM, et al. Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice. PLoS Genet (2010) 6(6):e1000980. doi:10.1371/journal.pgen.1000980
38. de Joussineau C, Sahut-Barnola I, Levy I, Saloustros E, Val P, Stratakis CA, et al. The cAMP pathway and the control of adrenocortical development and growth. Mol Cell Endocrinol (2012) 351(1):28-36. doi:10.1016/j.mce.2011.10.006
39. de Joussineau C, Sahut-Barnola I, Tissier F, Dumontet T, Drelon C, Batisse-Lignier M, et al. mTOR pathway is activated by PKA in adrenocortical cells and participates in vivo to apoptosis resistance in primary pigmented nodular adrenocortical disease (PPNAD). Hum Mol Genet (2014) 23(20):5418-28. doi:10.1093/hmg/ddu265
40. Berthon A, Sahut-Barnola I, Lambert-Langlais S, de Joussineau C, Damon-Soubeyrand C, Louiset E, et al. Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Hum Mol Genet (2010) 19(8):1561-76. doi:10.1093/hmg/ddq029
41. Huang CC, Miyagawa S, Matsumaru D, Parker KL, Yao HH. Progenitor cell expansion and organ size of mouse adrenal is regulated by sonic hedgehog. Endocrinology (2010) 151(3):1119-28. doi:10.1210/en.2009-0814
42. Tetteh PW, Farin HF, Clevers H. Plasticity within stem cell hierarchies in mammalian epithelia. Trends Cell Biol (2015) 25(2):100-8. doi:10.1016/j.tcb.2014.09.003
43. Guasti L, Candy Sze WC, McKay T, Grose R, King PJ. FGF signalling through Fgfr2 isoform IIIb regulates adrenal cortex development. Mol Cell Endocrinol (2013) 371(1-2):182-8. doi:10.1016/j.mce.2013.01.014
44. Parviainen H, Schrade A, Kiiveri S, Prunskaite-Hyyrylainen R, Haglund C, Vainio S, et al. Expression of Wnt and TGF-beta pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness. Pathol Res Pract (2013) 209(8):503-9. doi:10.1016/j.prp.2013.06.002
45. Stone DM, Hynes M, Armanini M, Swanson TA, Gu Q, Johnson RL, et al. The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature (1996) 384(6605):129-34. doi:10.1038/384129a0
46. Finco I, LaPensee CR, Krill KT, Hammer GD. Hedgehog signaling and steroidogenesis. Annu Rev Physiol (2015) 77:105-29. doi:10.1146/annurev-physiol-061214-111754
47. Pan Y, Bai CB, Joyner AL, Wang B. Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation. Mol Cell Biol (2006) 26(9):3365-77. doi:10.1128/MCB.26.9.3365-3377.2006
48. Vokes SA, Ji H, McCuine S, Tenzen T, Giles S, Zhong S, et al. Genomic characterization of Gli-activator targets in sonic hedgehog-mediated neural patterning. Development (2007) 134(10):1977-89. doi:10.1242/dev.001966
49. Ching S, Vilain E. Targeted disruption of Sonic hedgehog in the mouse adrenal leads to adrenocortical hypoplasia. Genesis (2009) 47(9):628-37. doi:10.1002/dvg.20532
50. Sul HS. Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate. Mol Endocrinol (2009) 23(11):1717-25. doi:10.1210/me.2009-0160
51. Halder SK, Takemori H, Hatano O, Nonaka Y, Wada A, Okamoto M. Cloning of a membrane-spanning protein with epidermal growth factor-like repeat motifs from adrenal glomerulosa cells. Endocrinology (1998) 139(7):3316-28. doi:10.1210/endo.139.7.6081
52. Zhang P, Greendorfer JS, Jiao J, Kelpke SC, Thompson JA. Alternatively spliced FGFR-1 isoforms differentially modulate endothelial cell activation of c-YES. Arch Biochem Biophys (2006) 450(1):50-62. doi:10.1016/j.abb.2006.03.017
53. Katoh M. Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells. Curr Pharm Biotechnol (2011) 12(2):160-70. doi:10.2174/138920111794295710
54. Chu Y, Ho WJ, Dunn JC. Basic fibroblast growth factor delivery enhances adrenal cortical cellular regeneration. Tissue Eng Part A (2009) 15(8):2093-101. doi:10.1089/ten.tea.2008.0305
55. Crickard K, Ill CR, Jaffe RB. Control of proliferation of human fetal adrenal cells in vitro. J Clin Endocrinol Metab (1981) 53(4):790-6. doi:10.1210/jcem-53-4-790
56. Gospodarowicz D, Ill CR, Hornsby PJ, Gill GN. Control of bovine adrenal cortical cell proliferation by fibroblast growth factor. Lack of effect of epidermal growth factor. Endocrinology (1977) 100(4):1080-9. doi:10.1210/endo-100-4-1080
57. Lepique AP, Moraes MS, Rocha KM, Eichler CB, Hajj GN, Schwindt TT, et al. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells. J Mol Endocrinol (2004) 33(3):623-38. doi:10.1677/jme.1.01485
58. Basile DP, Holzwarth MA. Basic fibroblast growth factor receptor in the rat adrenal cortex: effects of suramin and unilateral adrenalectomy on receptor numbers. Endocrinology (1994) 134(6):2482-9. doi:10.1210/en.134.6.2482
59. Revest JM, Spencer-Dene B, Kerr K, De Moerlooze L, Rosewell I, Dickson C. Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. Dev Biol (2001) 231(1):47-62. doi:10.1006/dbio.2000.0144
60. Kim Y, Bingham N, Sekido R, Parker KL, Lovell-Badge R, Capel B. Fibroblast growth factor receptor 2 regulates proliferation and Sertoli differentiation during male sex determination. Proc Natl Acad Sci U S A (2007) 104(42):16558-63. doi:10.1073/pnas.0702581104
61. Kim AC, Reuter AL, Zubair M, Else T, Serecky K, Bingham NC, et al. Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development (2008) 135(15):2593-602. doi:10.1242/dev.021493
62. Berthon A, Martinez A, Bertherat J, Val P. Wnt/beta-catenin signalling in adrenal physiology and tumour development. Mol Cell Endocrinol (2012) 351(1):87-95. doi:10.1016/j.mce.2011.09.009
63. Christofer Juhlin C, Goh G, Healy JM, Fonseca AL, Scholl UI, Stenman A, et al. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma. J Clin Endocrinol Metab (2014) 9:jc20143282. doi:10.1210/jc.2014-3282
64. Benhamouche S, Decaens T, Godard C, Chambrey R, Rickman DS, Moinard C, et al. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev Cell (2006) 10(6):759-70. doi:10.1016/j.devcel.2006.03.015
65. Drelon C, Berthon A, Ragazzon B, Tissier F, Bandiera R, Sahut-Barnola I, et al. Analysis of the role of Igf2 in adrenal tumour development in transgenic mouse models. PLoS One (2012) 7(8):e44171. doi:10.1371/journal.pone.0044171
66. Berthon A, Drelon C, Ragazzon B, Boulkroun S, Tissier F, Amar L, et al. WNT/beta-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. Hum Mol Genet (2014) 23(4):889-905. doi:10.1093/hmg/ddt484
67. Drelon C, Berthon A, Mathieu M, Martinez A, Val P. Adrenal cortex tissue homeostasis and zonation: a WNT perspective. Mol Cell Endocrinol (2015). doi:10.1016/j.mce.2014.12.014
68. Walczak EM, Kuick R, Finco I, Bohin N, Hrycaj SM, Wellik DM, et al. Wnt signaling inhibits adrenal steroidogenesis by cell-autonomous and non-cell-autonomous mechanisms. Mol Endocrinol (2014) 28(9):1471-86. doi:10.1210/me.2014-1060
69. Heikkila M, Peltoketo H, Leppaluoto J, Ilves M, Vuolteenaho O, Vainio S. Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology (2002) 143(11):4358-65. doi:10.1210/en.2002-220275
70. Suwa T, Chen M, Hawks CL, Hornsby PJ. Zonal expression of dickkopf-3 and components of the Wnt signalling pathways in the human adrenal cortex. J Endocrinol (2003) 178(1):149-58. doi:10.1677/joe.0.1780149
71. Röhrig T, Pihlajoki M, Ziegler R, Cochran RS, Schrade A, Schillebeeckx M, et al. Toying with fate: redirecting the differentiation of adrenocortical progenitor cells into gonadal-like tissue. Mol Cell Endocrinol (2015). doi:10.1016/j.mce.2014.12.003
72. Hsu SY, Liang SG, Hsueh AJ. Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region. Mol Endocrinol (1998) 12(12):1830-45. doi:10.1210/mend.12.12.0211
73. Assié G, Letouze E, Fassnacht M, Jouinot A, Luscap W, Barreau O, et al. Integrated genomic characterization of adrenocortical carcinoma. Nat Genet (2014) 46(6):6. doi:10.1038/ng.2953
74. Bernichtein S, Petretto E, Jamieson S, Goel A, Aitman TJ, Mangion JM, et al. Adrenal gland tumorigenesis after gonadectomy in mice is a complex genetic trait driven by epistatic loci. Endocrinology (2007) 149(2):651-61. doi:10.1210/en.2007-0925
75. El Wakil A, Bandulik S, Guy N, Bendahhou S, Zennaro MC, Niehrs C, et al. Dkk3 is a component of the genetic circuitry regulating aldosterone biosynthesis in the adrenal cortex. Hum Mol Genet (2012) 21(22):4922-9. doi:10.1093/hmg/dds333
76. Fottner C, Hoeflich A, Wolf E, Weber MM. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis. Horm Metab Res (2004) 36(6):397-405. doi:10.1055/s-2004-814563
77. Drelon C, Berthon A, Val P. Adrenocortical cancer and IGF2: is the game over or our experimental models limited? J Clin Endocrinol Metab (2013) 98(2):505-7. doi:10.1210/jc.2012-3310
78. Belgorosky A, Baquedano MS, Guercio G, Rivarola MA. Expression of the IGF and the aromatase/estrogen receptor systems in human adrenal tissues from early infancy to late puberty: implications for the development of adrenarche. Rev Endocr Metab Disord (2009) 10(1):51-61. doi:10.1007/s11154-008-9105-1
79. Pitetti JL, Calvel P, Romero Y, Conne B, Truong V, Papaioannou MD, et al. Insulin and IGF1 receptors are essential for XX and XY gonadal differentiation and adrenal development in mice. PLoS Genet (2013) 9(1):e1003160. doi:10.1371/journal.pgen.1003160
80. Penhoat A, Rainey WE, Viard I, Saez JM. Regulation of adrenal cell-differentiated functions by growth factors. Horm Res (1994) 42(1-2):39-43. doi:10.1159/000184143
81. Itoh F, Watabe T, Miyazono K. Roles of TGF-beta family signals in the fate determination of pluripotent stem cells. Semin Cell Dev Biol (2014) 32:98-106. doi:10.1016/j.semcdb.2014.05.017
82. Kumar TR, Donehower LA, Bradley A, Matzuk MM. Transgenic mouse models for tumour-suppressor genes. J Intern Med (1995) 238(3):233-8. doi:10.1111/j.1365-2796.1995.tb00928.x
83. Vanttinen T, Liu J, Kuulasmaa T, Kivinen P, Voutilainen R. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis. J Endocrinol (2003) 178(3):479-89. doi:10.1677/joe.0.1780479
84. Looyenga BD, Hammer GD. Genetic removal of Smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery. Mol Endocrinol (2007) 21(10):18. doi:10.1210/me.2006-0402
85. Looyenga BD, Wiater E, Vale W, Hammer GD. Inhibin-A antagonizes TGFbeta2 signaling by down-regulating cell surface expression of the TGFbeta coreceptor betaglycan. Mol Endocrinol (2010) 24(3):608-20. doi:10.1210/me.2008-0374
86. Schillebeeckx M, Pihlajoki M, Gretzinger E, Yang W, Thol F, Hiller T, et al. Novel markers of gonadectomy-induced adrenocortical neoplasia. Mol Cell Endocrinol (2015) 399:122-30. doi:10.1016/j.mce.2014.09.029
87. Baba T, Otake H, Sato T, Miyabayashi K, Shishido Y, Wang CY, et al. Glycolytic genes are targets of the nuclear receptor Ad4BP/SF-1. Nat Commun (2014) 5:3634. doi:10.1038/ncomms4634
88. Ruggiero C, Doghman M, Lalli E. How genomic studies have improved our understanding of the mechanisms of transcriptional regulation by NR5A nuclear receptors. Mol Cell Endocrinol (2015). doi:10.1016/j.mce.2014.10.022
89. Urs AN, Dammer E, Kelly S, Wang E, Merrill AH Jr, Sewer MB. Steroidogenic factor-1 is a sphingolipid binding protein. Mol Cell Endocrinol (2007) 265-266:174-8. doi:10.1016/j.mce.2006.12.016
90. Blind RD, Suzawa M, Ingraham HA. Direct modification and activation of a nuclear receptor-PIP2 complex by the inositol lipid kinase IPMK. Sci Signal (2012) 5(229):ra44. doi:10.1126/scisignal.2003111
91. Parker KL. The roles of steroidogenic factor 1 in endocrine development and function. Mol Cell Endocrinol (1998) 145(1-2):15-20. doi:10.1016/S0303-7207(98)00164-6
92. Lichtenauer UD, Duchniewicz M, Kolanczyk M, Hoeflich A, Hahner S, Else T, et al. Pre-B-cell transcription factor 1 and steroidogenic factor 1 synergistically regulate adrenocortical growth and steroidogenesis. Endocrinology (2007) 148(2):693-704. doi:10.1210/en.2006-0681
93. Beuschlein F, Mutch C, Bavers DL, Ulrich-Lai YM, Engeland WC, Keegan C, et al. Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology (2002) 143(8):3122-35. doi:10.1210/endo.143.8.8944
94. Figueiredo BC, Cavalli LR, Pianovski MA, Lalli E, Sandrini R, Ribeiro RC, et al. Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. J Clin Endocrinol Metab (2005) 90(2):615-9. doi:10.1210/jc.2004-0942
95. Doghman M, Karpova T, Rodrigues GA, Arhatte M, De MJ, Cavalli LR, et al. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol (2007) 21(12):2968-87. doi:10.1210/me.2007-0120
96. Latre de Late P, Wakil AE, Jarjat M, de Krijger RR, Heckert LL, Naquet P, et al. Vanin-1 inactivation antagonizes the development of adrenocortical neoplasia in Sf-1 transgenic mice. Endocrinology (2014) 155(7):16. doi:10.1210/en.2014-1088
97. Lee FY, Faivre EJ, Suzawa M, Lontok E, Ebert D, Cai F, et al. Eliminating SF-1 (NR5A1) sumoylation in vivo results in ectopic hedgehog signaling and disruption of endocrine development. Dev Cell (2011) 21(2):315-27. doi:10.1016/j.devcel.2011.06.028
98. Lalli E, Melner MH, Stocco DM, Sassone-Corsi P. DAX-1 blocks steroid production at multiple levels. Endocrinology (1998) 139(10):4237-43. doi:10.1210/en.139.10.4237
99. Achermann JC, Meeks JJ, Jameson JL. Phenotypic spectrum of mutations in DAX-1 and SF-1. Mol Cell Endocrinol (2001) 185(1-2):17-25. doi:10.1016/S0303-7207(01)00619-0
100. Scheys JO, Heaton JH, Hammer GD. Evidence of adrenal failure in aging Dax1-deficient mice. Endocrinology (2011) 152(9):3430-9. doi:10.1210/en.2010-0986
101. Zazopoulos E, Lalli E, Stocco DM, Sassone-Corsi P. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature (1997) 390(6657):311-5. doi:10.1038/36899
102. Cui S, Ross A, Stallings N, Parker KL, Capel B, Quaggin SE. Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice. Development (2004) 131(16):4095-105. doi:10.1242/dev.01266
103. Kim AC, Hammer GD. Adrenocortical cells with stem/progenitor cell properties: recent advances. Mol Cell Endocrinol (2007) 26(5-266):10-6. doi:10.1016/j.mce.2006.12.028
104. Bandiera R, Sacco S, Vidal VP, Chaboissier MC, Schedl A. Steroidogenic organ development and homeostasis: a WT1-centric view. Mol Cell Endocrinol (2015). doi:10.1016/j.mce.2015.01.009
105. Kiiveri S, Liu J, Westerholm-Ormio M, Narita N, Wilson DB, Voutilainen R, et al. Differential expression of GATA-4 and GATA-6 in fetal and adult mouse and human adrenal tissue. Endocrinology (2002) 143(8):3136-43. doi:10.1210/endo.143.8.8939
106. Pihlajoki M, Gretzinger E, Cochran R, Kyrönlahti A, Schrade A, Hiller T, et al. Conditional mutagenesis of Gata6 in SF1-positive cells causes gonadal-like differentiation in the adrenal cortex of mice. Endocrinology (2013) 154(5):1754-67. doi:10.1210/en.2012-1892
107. Padua MB, Jiang T, Morse DA, Fox SC, Hatch HM, Tevosian SG. Combined loss of the GATA4 and GATA6 transcription factors in male mice disrupts testicular development and confers adrenal-like function in the testes. Endocrinology (2015). doi:10.1210/en.2014-1907
108. Zhang Y, Goss AM, Cohen ED, Kadzik R, Lepore JJ, Muthukumaraswamy K, et al. A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat Genet (2008) 40(7):862-70. doi:10.1038/ng.157
109. Tian Y, Zhang Y, Hurd L, Hannenhalli S, Liu F, Lu MM, et al. Regulation of lung endoderm progenitor cell behavior by miR302/367. Development (2011) 138(7):1235-45. doi:10.1242/dev.061762
110. Beuling E, Baffour-Awuah NY, Stapleton KA, Aronson BE, Noah TK, Shroyer NF, et al. GATA factors regulate proliferation, differentiation, and gene expression in small intestine of mature mice. Gastroenterology (2011) 140(4):e1-2. doi:10.1053/j.gastro.2011.01.033
111. Beuling E, Aronson BE, Tran LM, Stapleton KA, Ter Horst EN, Vissers LA, et al. GATA6 is required for proliferation, migration, secretory cell maturation, and gene expression in the mature mouse colon. Mol Cell Biol (2012) 32(17):3392-402. doi:10.1128/MCB.00070-12
112. Whissell G, Montagni E, Martinelli P, Hernando-Momblona X, Sevillano M, Jung P, et al. The transcription factor GATA6 enables self-renewal of colon adenoma stem cells by repressing BMP gene expression. Nat Cell Biol (2014) 16(7):695-707. doi:10.1038/ncb2992
113. Tsuji S, Kawasaki Y, Furukawa S, Taniue K, Hayashi T, Okuno M, et al. The miR-363-GATA6-Lgr5 pathway is critical for colorectal tumourigenesis. Nat Commun (2014) 5:3150. doi:10.1038/ncomms4150
114. Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science (2014) 345(6194):1247125. doi:10.1126/science.1247125